Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic Therapy - Concepedia

Concepedia

Publication | Open Access

Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic Therapy

DOI Full Paper Access

26

Citations

15

References

2020

Year

Roberto Bertè, Stefano Mazza, Marta Rachele Stefanucci, Daniele Noviello, Stefania Costa, Clorinda Ciafardini, Erika Mileti, Marina Mapelli, Sebastiano Pasqualato, Sergio Pinto,

Journal of Crohn s and Colitis

Abstract

Seroprevalence of SARS-CoV2 in IBD patients treated with biologic therapy reflects values measured in the local general population. Specific symptoms and contact history with SARS-CoV2-infected individuals strongly increase the likelihood of SARS-CoV2 seropositivity.

References

	Year	Citations

Page 1